Symbol="ADIL"
AssetType="Common Stock"
Name="Adial Pharmaceuticals Inc"
Description="Adial Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapies for the treatment or prevention of addictions and related disorders. The company is headquartered in Charlottesville, Virginia."
CIK="1513525"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="1180 SEMINOLE TRAIL, SUITE 495, CHARLOTTESVILLE, VA, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="15761500"
EBITDA="-13170611"
PERatio="None"
PEGRatio="None"
BookValue="0.05"
DividendPerShare="0"
DividendYield="0"
EPS="-0.49"
RevenuePerShareTTM="0"
ProfitMargin="0"
OperatingMarginTTM="0"
ReturnOnAssetsTTM="-0.922"
ReturnOnEquityTTM="-2.096"
RevenueTTM="0"
GrossProfitTTM="0"
DilutedEPSTTM="-0.49"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0"
AnalystTargetPrice="6"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="-"
PriceToBookRatio="1.179"
EVToRevenue="-"
EVToEBITDA="-0.0585"
Beta="0.872"
num_52WeekHigh="2.08"
num_52WeekLow="0.2"
num_50DayMovingAverage="0.273"
num_200DayMovingAverage="0.318"
SharesOutstanding="29942000"
DividendDate="None"
ExDividendDate="None"
symbol="ADIL"
open="0.29"
high="0.29"
low="0.26"
price="0.28"
volume="1163148.00"
latest_trading_day="2023-07-14"
previous_close="0.29"
change="-0.01"
change_percent="-4.6864%"
aroon_positive_momentum_days="36"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="High Volatility / Hold Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="36"
Volume_recent_avg="1848169"
Change_recent_avg="0.01"
Delta_recent_avg="0.05"
Variance_recent_avg="0.02"
Change_ratio_recent_avg="-1.44"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="36"
Aroon_momentum_negative="64"
image_negative_thumbnail_id_1="508"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0097.jpeg"
image_negative_thumbnail_id_2="1147"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0180.jpeg"
image_neutral_thumbnail_id_1="566"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0033.jpeg"
image_neutral_thumbnail_id_2="585"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0014.jpeg"
image_positive_thumbnail_id_1="620"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0088.jpeg"
image_positive_thumbnail_id_2="1166"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Negative_0187.jpeg"
image_professor_thumbnail_id_1="1199"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0033.jpeg"
image_professor_thumbnail_id_2="1196"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0030.jpeg"
